Inovio Pharma (INO) Stock Price, Quote & News

Company Profile

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company's lead product candidate is INO-3107 for HPV-...

Industry: Biotechnology

Sector: Healthcare

Phone: 267 440 4200

Website: www.inovio.com

Address:

660 West Germantown Pike, Suite 110, Plymouth Meeting, United States

Tracker7 Jul. 4 at 1:02 PM

$INO The United States of America! The greatest country in the world. A country of freedom! Don’t take it for granted. It’s a wonderful blessing to have been born and raised here.

1 · Reply

SheaMakePeePeeGrow Jul. 4 at 12:35 PM

$INO Robert the Rocket man aka @rioe @HARM20 @INOVIO is

1 · Reply

updownsides Jul. 4 at 9:04 AM

$INO Offering date

0 · Reply

tommy571 Jul. 3 at 10:18 PM

$INO in corso di pandemia Covid-19 era a quasi 400 dollari. Senza alcuna commercializzazione. Se ora arrivano news concrete, il titolo va ben oltre.

1 · Reply

JackFrost25 Jul. 3 at 6:00 PM

$INO Right. Because no one with even cursory due diligence would have guessed that INO would drop announcement of a shelf or offering afterhours the day before a 3 days holiday weekend. Just completely out of character for Inovio

0 · Reply

rioe Jul. 3 at 3:58 PM

$INO Our journey won’t be stopped by paid bashers trying to tear down American innovation. The science is strong, the mission is clear, and no amount of noise changes the facts. God bless the United States of America. 🇺🇸🚀

1 · Reply

jabramowitz Jul. 3 at 3:25 PM

$INO Shea keep it on the shelf for a while please...

0 · Reply

Tracker7 Jul. 3 at 2:29 PM

$INO The first DNA plasmid medicines are on the way. Will it be INO-3107 in the USA and Europe? Or VGX-3100 in China? Hmmm…?

1 · Reply

TopShelf Jul. 3 at 12:12 PM

$INO 🇺🇸 🧬 🇺🇸 God Bless America.

0 · Reply

GermanBulle Jul. 3 at 8:00 AM

$INO very suspicious things happened here. Insider information spread b4 ??? But green close with such a news. Weird, very very weird. What will be released soon ? It must be very positive IMO.

0 · Reply

Inovio files $300M mixed securities shelf

Jul 2, 2026, 8:00 AM EDT - 2 days ago

Inovio Pharmaceuticals Registration statement: Registration filing

Jun 4, 2026, 8:45 AM EDT - 4 weeks ago

Inovio Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026

2026-06-01T10:38:41.000Z - 4 weeks ago

Inovio price target lowered to $2.50 from $3 at H.C. Wainwright

May 28, 2026, 8:05 AM EDT - 5 weeks ago

INOVIO to Participate in Upcoming Scientific and Investor Conferences

2026-05-21T20:21:04.000Z - 6 weeks ago

Inovio: ApolloBio announces ‘positive’ results from Phase 3 trial of VGX-3100

May 21, 2026, 4:05 PM EDT - 6 weeks ago

Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China

May 20, 2026, 9:00 AM EDT - 6 weeks ago

Inovio Pharmaceuticals Transcript: AGM 2026

May 13, 2026, 4:30 PM EDT - 7 weeks ago

Inovio Pharmaceuticals Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 7 weeks ago

Inovio Pharmaceuticals Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 7 weeks ago

Inovio Pharmaceuticals Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 7 weeks ago

Inovio Pharmaceuticals Slides: Q1 2026

May 13, 2026, 4:05 PM EDT - 7 weeks ago

INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights

May 11, 2026, 7:53 AM EDT - 7 weeks ago

Hantavirus cases spark surge in pharma and biotech stocks — here's why

EBS MRNA NVAX

May 8, 2026, 8:05 AM EDT - 2 months ago

INOVIO to Participate in Upcoming Scientific Conferences

May 1, 2026, 4:05 PM EDT - 2 months ago

INOVIO to Report First Quarter Financial Results on May 13, 2026

Apr 7, 2026, 8:00 AM EDT - 3 months ago

Inovio Pharmaceuticals Proxy statement: Proxy filing

Apr 2, 2026, 8:55 AM EDT - 3 months ago

INOVIO Announces Pricing of $17.5 Million Public Offering

Apr 1, 2026, 8:05 PM EDT - 3 months ago

INOVIO Announces Proposed Public Offering

Apr 1, 2026, 10:29 AM EDT - 3 months ago

INOVIO to Participate in Upcoming Scientific Conference

2026-03-23T12:41:57.000Z - 3 months ago

Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims

Mar 23, 2026, 8:00 AM EDT - 3 months ago

Inovio Pharmaceuticals Slides: Corporate presentation

Mar 12, 2026, 4:30 PM EDT - 4 months ago

Inovio Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 4 months ago

Inovio Pharmaceuticals Earnings release: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 4 months ago

Inovio Pharmaceuticals Annual report: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 4 months ago

Inovio Pharmaceuticals Slides: Q4 2025

Mar 12, 2026, 4:05 PM EDT - 4 months ago

INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Mar 10, 2026, 1:40 PM EDT - 4 months ago

Inovio Pharmaceuticals Transcript: The Citizens Life Sciences Conference 2026

Mar 5, 2026, 4:05 PM EST - 4 months ago

INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

Mar 4, 2026, 8:52 AM EST - 4 months ago

Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)

2026-03-04T13:15:14.000Z - 4 months ago

Inovio, Akeso announce clinical collaboration

Mar 4, 2026, 8:05 AM EST - 4 months ago

INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)

Feb 25, 2026, 12:40 PM EST - 4 months ago

Inovio Pharmaceuticals Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference

2025-12-29T13:10:42.000Z - 6 months ago

Inovio announces U.S. FDA accepted BLA for INO-3107

Dec 29, 2025, 8:05 AM EST - 6 months ago

FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

Dec 19, 2025, 4:05 PM EST - 7 months ago

INOVIO Reports Inducement Grant Under Inducement Plan

Dec 2, 2025, 8:30 AM EST - 7 months ago

Inovio Pharmaceuticals Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 8:05 AM EST - 8 months ago

INOVIO to Participate in December Investor Conferences

2025-11-14T11:45:36.000Z - 8 months ago

Inovio price target raised to $6 from $5 at Piper Sandler

2025-11-11T13:45:25.000Z - 8 months ago

Inovio 13.16M share Spot Secondary priced at $1.90

Nov 11, 2025, 8:40 AM EST - 8 months ago

INOVIO Announces Pricing of $25 Million Public Offering

2025-11-10T23:20:12.000Z - 8 months ago

Inovio announces common stock offering, no amount given

Nov 10, 2025, 4:30 PM EST - 8 months ago

Inovio Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 10, 2025, 4:30 PM EST - 8 months ago

Inovio Pharmaceuticals Earnings release: Q3 2025

Nov 10, 2025, 4:30 PM EST - 8 months ago

Inovio Pharmaceuticals Quarterly report: Q3 2025

Nov 10, 2025, 4:30 PM EST - 8 months ago

Inovio Pharmaceuticals Slides: Q3 2025

Nov 10, 2025, 4:05 PM EST - 8 months ago

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

2025-11-03T13:10:55.000Z - 8 months ago

Inovio completes rolling submission of BLA for INO-3107

Nov 3, 2025, 8:05 AM EST - 8 months ago

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Oct 27, 2025, 8:05 AM EDT - 8 months ago

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

Oct 23, 2025, 4:05 PM EDT - 9 months ago

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

Oct 21, 2025, 8:05 AM EDT - 9 months ago

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

Sep 5, 2025, 7:00 AM EDT - 10 months ago

Inovio Pharmaceuticals Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Aug 26, 2025, 8:05 AM EDT - 11 months ago

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults

Aug 25, 2025, 8:05 AM EDT - 11 months ago

INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Inovio Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Inovio Pharmaceuticals Earnings release: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

Inovio Pharmaceuticals Quarterly report: Q2 2025

Aug 12, 2025, 4:05 PM EDT - 11 months ago

INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Aug 11, 2025, 8:05 AM EDT - 11 months ago

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Aug 4, 2025, 4:05 PM EDT - 11 months ago

INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 7, 2025, 4:05 PM EDT - 1 year ago

INOVIO to Present at Upcoming Scientific Conference

Jul 1, 2025, 7:00 AM EDT - 1 year ago

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

Jun 17, 2025, 7:00 AM EDT - 1 year ago

Inovio Pharmaceuticals Slides: Corporate Presentation

May 13, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Quarterly report: Q1 2025

May 13, 2025, 4:05 PM EDT - 1 year ago

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights

May 8, 2025, 11:30 AM EDT - 1 year ago

Inovio Pharmaceuticals Transcript: The Citizens JMP Life Sciences Conference 2025

Apr 30, 2025, 8:05 AM EDT - 1 year ago

INOVIO to Present at Upcoming Scientific and Investor Conferences

Apr 29, 2025, 8:05 AM EDT - 1 year ago

INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 9, 2025, 8:05 AM EDT - 1 year ago

INOVIO to Present at Upcoming Scientific Conferences

Apr 7, 2025, 8:00 AM EDT - 1 year ago

Inovio Pharmaceuticals Proxy statement: Proxy Filing

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Earnings Call Transcript: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Earnings release: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Inovio Pharmaceuticals Annual report: Q4 2024

Mar 18, 2025, 4:05 PM EDT - 1 year ago

INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Mar 13, 2025, 6:15 PM EDT - 1 year ago

INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19

Mar 12, 2025, 12:55 PM EDT - 1 year ago

INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025

Feb 12, 2025, 3:20 PM EST - 1 year ago

Inovio Pharmaceuticals Transcript: Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025

Feb 12, 2025, 8:00 AM EST - 1 year ago

Clinical and Immunological Results from Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications

Tracker7 Jul. 4 at 1:02 PM

$INO The United States of America! The greatest country in the world. A country of freedom! Don’t take it for granted. It’s a wonderful blessing to have been born and raised here.

1 · Reply

SheaMakePeePeeGrow Jul. 4 at 12:35 PM

$INO Robert the Rocket man aka @rioe @HARM20 @INOVIO is

1 · Reply

updownsides Jul. 4 at 9:04 AM

$INO Offering date

0 · Reply

tommy571 Jul. 3 at 10:18 PM

$INO in corso di pandemia Covid-19 era a quasi 400 dollari. Senza alcuna commercializzazione. Se ora arrivano news concrete, il titolo va ben oltre.

1 · Reply

JackFrost25 Jul. 3 at 6:00 PM

0 · Reply

rioe Jul. 3 at 3:58 PM

1 · Reply

jabramowitz Jul. 3 at 3:25 PM

$INO Shea keep it on the shelf for a while please...

0 · Reply

Tracker7 Jul. 3 at 2:29 PM

$INO The first DNA plasmid medicines are on the way. Will it be INO-3107 in the USA and Europe? Or VGX-3100 in China? Hmmm…?

1 · Reply

TopShelf Jul. 3 at 12:12 PM

$INO 🇺🇸 🧬 🇺🇸 God Bless America.

0 · Reply

GermanBulle Jul. 3 at 8:00 AM

$INO very suspicious things happened here. Insider information spread b4 ??? But green close with such a news. Weird, very very weird. What will be released soon ? It must be very positive IMO.

0 · Reply

Jrtreats Jul. 3 at 5:00 AM

$INO if Shea and company doesn't cut our legs out from under us again, she ready to run. Shea be patient, let it run then raise if we must after great news is released. We are good till 1st quarter 27.

1 · Reply

updownsides Jul. 3 at 1:30 AM

$INO OMG!!! Shea got her new credit card. She's going to max it out on your dime. What does she care. Insiders hold squat. Now she can guarantee her paycheck thru the next reverse split.

0 · Reply

Luckyizme Jul. 3 at 1:12 AM

$INO 1.30's+ next wk.

0 · Reply

SheaMakePeePeeGrow Jul. 3 at 12:30 AM

$INO that’s why I’m rich and you’re not, Robert

1 · Reply

INOVIO Jul. 3 at 12:07 AM

$INO @SheaMakePeePeeGrow The fact that you knew this was happening in the AH today is very suspicious.

2 · Reply

tau72 Jul. 2 at 9:25 PM

$INO now only have 1 position for contractor (3rd party). Looks like they either already finished hiring ppl they need or removed them. Shea ready to go shopping for the buyers...

0 · Reply

TTC4318 Jul. 2 at 9:11 PM

$INO fleecing investors yet again. Wtf

0 · Reply

Skibum77 Jul. 2 at 9:09 PM

$INO this company is such a piece of shit and has been for decades God they’re just unbelievable More dilution they sure can’t spend money. Just don’t know how to make it

2 · Reply

tau72 Jul. 2 at 9:04 PM

$INO their total employees is 112 now. Down from 173 last year, I believe. Great deal for the take over, yeah

0 · Reply

JackFrost25 Jul. 2 at 9:00 PM

$INO Shelf registration of $300 million announced. 3x their market cap. OK inovio lol

1 · Reply

tau72 Jul. 2 at 8:54 PM

$INO Is the S3 form filed today renewal from last year?

1 · Reply

Luckyizme Jul. 2 at 8:53 PM

$INO LOL. Someone just sold their wad already. They havnt even pumped it yet.

0 · Reply

Market Cap	100.37M
Revenue (ttm)	70,000.00
Net Income (ttm)	-84.95M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-121,357.14%
Debt to Equity Ratio	0.00

Volume	2,771,100
Avg Vol	2,529,380
Day's Range	N/A - N/A
Shares Out	82.27M
Stochastic %K	74%
Beta	1.48
Analysts	Sell
Price Target	$5.83